Nurix Therapeutics, Inc. (NRIX)

NASDAQ: NRIX · Real-Time Price · USD

11.62

+0.23 (2.02%)

Jun 18, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is December - November.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2018 - 2019
Small Molecule and Cell Therapies	54.55M	Log In	Log In	Log In	Log In	Upgrade
Small Molecule and Cell Therapies Growth	-29.15%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is December - November.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Nov '24 Nov 30, 2024	Nov '23 Nov 30, 2023	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	2018 - 2019
United States	54.55M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-29.15%	Log In	Log In	Log In	Log In	Upgrade